Keqian Biotech announced that the porcine circovirus type 2 recombinant bacuvirus and Mycoplasma porcine pneumoniae double inactivated vaccine (KQ strain +XJ03 strain) declared by the company obtained a new veterinary drug registration certificate. The vaccine is used to prevent diseases related to porcine circovirus type 2 and Mycoplasma porcine pneumoniae infection. The immunization period is 14 days after the second immunization period, and the duration of immunity is 4 months. Approval of new products will enrich the company's product range, promote diversified business development, and enhance market competitiveness. However, it is necessary to obtain an approval number before the product is marketed, and there are uncertainties and marketing risks.